{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:23:26Z","timestamp":1783149806509,"version":"3.54.6"},"reference-count":46,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ymgme.2022.08.008","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T02:35:15Z","timestamp":1662086115000},"page":"187-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Hermansky-Pudlak syndrome: Gene therapy for pulmonary fibrosis"],"prefix":"10.1016","volume":"137","author":[{"given":"Gustavo","family":"Nieto-Alamilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Behan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahin","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette R.","family":"Gochuico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May Christine V.","family":"Malicdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2022.08.008_bb0005","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/humu.23968","article-title":"Hermansky-Pudlak syndrome: mutation update","volume":"41","author":"Huizing","year":"2020","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/joim.13224","article-title":"Inflammatory bowel disease in Hermansky-Pudlak syndrome: a retrospective single-centre cohort study","volume":"290","author":"O\u2019Brien","year":"2021","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0015","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0193-2020","article-title":"Hermansky-Pudlak syndrome pulmonary fibrosis: a rare inherited interstitial lung disease","volume":"30","author":"Yokoyama","year":"2021","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0020","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/s41436-020-0867-5","article-title":"BLOC1S5 pathogenic variants cause a new type of Hermansky-Pudlak syndrome","volume":"22","author":"Pennamen","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0025","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1038\/s41598-020-60931-5","article-title":"Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7","volume":"10","author":"Romano","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0030","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0035","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2119\/molmed.2011.00198","article-title":"Interstitial lung disease and pulmonary fibrosis in Hermansky-Pudlak syndrome type 2, an adaptor protein-3 complex disease","volume":"18","author":"Gochuico","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00439-003-0933-5","article-title":"Hermansky-Pudlak syndrome type 4 (HPS-4): clinical and molecular characteristics","volume":"113","author":"Anderson","year":"2003","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0045","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1182\/blood-2015-09-671636","article-title":"Mutations in AP3D1 associated with immunodeficiency and seizures define a new type of Hermansky-Pudlak syndrome","volume":"127","author":"Ammann","year":"2016","journal-title":"Blood."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0050","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1164\/rccm.201407-1287OC","article-title":"Circulating fibrocytes as biomarker of prognosis in Hermansky-Pudlak syndrome","volume":"190","author":"Trimble","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1165\/rcmb.2021-0557TR","article-title":"Insights into the pathogenesis of pulmonary fibrosis from genetic diseases","volume":"67","author":"Wang","year":"2022","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0060","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88947","article-title":"Epithelial-macrophage interactions determine pulmonary fibrosis susceptibility in Hermansky-Pudlak syndrome","volume":"1","author":"Young","year":"2016","journal-title":"JCI Insight."},{"issue":"7","key":"10.1016\/j.ymgme.2022.08.008_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159177","article-title":"Immunophenotypic and ultrastructural analysis of mast cells in Hermansky-Pudlak syndrome type-1: a possible connection to pulmonary fibrosis","volume":"11","author":"Kirshenbaum","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2022.08.008_bb0070","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20092121","article-title":"Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent","volume":"207","author":"Wilson","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0075","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"ASCEND Study Group. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0080","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0085","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1164\/rccm.200901-0023OC","article-title":"Alveolar macrophage dysregulation in Hermansky-Pudlak syndrome type 1","volume":"180","author":"Rouhani","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0090","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1096-7192(02)00044-6","article-title":"Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome","volume":"76","author":"Gahl","year":"2002","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0095","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ymgme.2011.02.003","article-title":"Pirfenidone for the treatment of Hermansky-Pudlak syndrome pulmonary fibrosis","volume":"103","author":"O\u2019Brien","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0100","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ymgme.2018.07.012","article-title":"Prolonged treatment with open-label pirfenidone in Hermansky-Pudlak syndrome pulmonary fibrosis","volume":"125","author":"O\u2019Brien","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0105","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194193","article-title":"Clinical management and outcomes of patients with Hermansky-Pudlak syndrome pulmonary fibrosis evaluated for lung transplantation","volume":"13","author":"El-Chemaly","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2022.08.008_bb0115","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan4672","article-title":"Gene therapy comes of age","volume":"359","author":"Dunbar","year":"2018","journal-title":"Science."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0120","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1038\/s41467-020-19505-2","article-title":"The once and future gene therapy","volume":"11","author":"Bulaklak","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ymgme.2014.11.006","article-title":"In vitro functional correction of Hermansky-Pudlak syndrome type-1 by lentiviral-mediated gene transfer","volume":"114","author":"Ikawa","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0130","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1165\/rcmb.2013-0025OC","article-title":"Dysregulation of galectin-3. Implications for Hermansky-Pudlak syndrome pulmonary fibrosis","volume":"50","author":"Cullinane","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0135","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0140","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nrg2971","article-title":"State-of-the-art gene-based therapies: the road ahead","volume":"12","author":"Kay","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0145","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jgm.646","article-title":"Methodological optimization of polyethylenimine (PEI)-based gene delivery to the lungs of mice via aerosol application","volume":"7","author":"Rudolph","year":"2005","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0150","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0155","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S2213-2600(16)00023-0","article-title":"Progress in therapies for cystic fibrosis","volume":"4","author":"De Boeck","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0160","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jcf.2021.05.014","article-title":"Comparison of Cas9 and Cas12a CRISPR editing methods to correct the W1282X-CFTR mutation","volume":"21","author":"Santos","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0165","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1076-8","article-title":"Precise therapeutic gene correction by a simple nuclease-induced double-stranded break","volume":"568","author":"Iyer","year":"2019","journal-title":"Nature."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0170","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3389\/fonc.2020.01387","article-title":"CRISPR gene therapy: applications, limitations, and implications for the future","volume":"10","author":"Uddin","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0175","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/mt.2012.194","article-title":"Endgame: glybera finally recommended for approval as the first gene therapy drug in the European union","volume":"20","author":"Yl\u00e4-Herttuala","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0180","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0185","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1165\/rcmb.2019-0006OC","article-title":"A novel AAV-mediated gene delivery system corrects CFTR function in pigs","volume":"61","author":"Cooney","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019919","article-title":"Common gene therapy viral vectors do not efficiently penetrate sputum from cystic fibrosis patients","volume":"6","author":"Hida","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2022.08.008_bb0195","article-title":"Effective viral-mediated lung gene therapy: is airway surface preparation necessary?","author":"McCarron","year":"2022","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0200","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41551-021-00786-x","article-title":"Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs","volume":"5","author":"Lokugamage","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0205","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41420-019-0147-9","article-title":"Alveolar type 2 progenitor cells for lung injury repair","volume":"5","author":"Olajuyin","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.471","article-title":"CB1 R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky-Pudlak syndrome","volume":"11","author":"Cinar","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0215","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2967\/jnumed.121.261925","article-title":"Fibroblast activation protein-specific PET\/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study","volume":"63","author":"R\u00f6hrich","year":"2022","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0220","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1165\/rcmb.2017-0324MA","article-title":"Gene-edited MLE-15 cells as a model for the Hermansky-Pudlak syndromes","volume":"58","author":"Kook","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0225","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12931-022-02002-z","article-title":"Progressive pulmonary fibrosis in a murine model of Hermansky-Pudlak syndrome","volume":"23","author":"Abudi-Sinreich","year":"2022","journal-title":"Respir. Res."},{"key":"10.1016\/j.ymgme.2022.08.008_bb0230","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/ncb3510","article-title":"A three-dimensional model of human lung development and disease from pluripotent stem cells","volume":"19","author":"Chen","year":"2017","journal-title":"Nat. Cell Biol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671922200395X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671922200395X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:54:55Z","timestamp":1761090895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109671922200395X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":46,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S109671922200395X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2022.08.008","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hermansky-Pudlak syndrome: Gene therapy for pulmonary fibrosis","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2022.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}